Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease

Clinical trial NCT06873334 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06873334
Sponsor: Skyhawk Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Huntington Disease Huntingtons Disease

Start date: 2025-05-27
Primary completion: 2027-05-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.